Latest Headlines

  1. Leica Biosystems And CellCarta Expand Collaborative Companion Diagnostic Development Model To Accelerate Commercialization Globally 6/1/2026
  2. Andelyn Biosciences Establishes The Andelyn Foundation To Support Families Living With Rare And Ultra-Rare Diseases 5/29/2026

    Andelyn Biosciences Inc., a patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the unveiling of The Andelyn Foundation, a nonprofit organization dedicated to supporting families living with rare and ultra-rare diseases through awareness, fundraising, and compassionate community engagement.

  3. Andelyn Biosciences Launches LVV Curator® Platform, Bringing Proven Viral Vector Platform Pedigree To Lentiviral Vector Manufacturing For Cell Therapies 5/29/2026

    Andelyn Biosciences, a leading cell and gene therapy contract development and manufacturing organization (CDMO), today announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.

  4. Andelyn Biosciences Receives Dark Horse Consulting Certification Of Gene Therapy Manufacturing Systems And Capabilities Within Its Initiative For Certification Of Manufacturing Capabilities (ICMC™) Program 5/29/2026

    Andelyn Biosciences, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced it has received full certification under the Initiative for Certification of Manufacturing Capabilities (ICMC) program from Dark Horse Consulting, recognizing the company’s capability to support advanced therapies manufacturing with its quality and production systems.

  5. AGC Biologics To Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance 5/28/2026

    AGC Biologics to provide process development and GMP manufacturing for a novel therapy, leveraging its global microbial network across Germany and Japan.

  6. Minaris Expands Rapid Mycoplasma Detection Services With bioMérieux's BIOFIRE® Platform To Reduce Turnaround Time For Release And In-Process Testing 5/27/2026

    Minaris Advanced Testing now offers an additional rapid PCR mycoplasma testing method to support accelerated lot release for advanced therapies and reduce overall development and manufacturing timelines.

  7. Flexible Production: Körber Presents New Inspection And Packaging Innovations For The Global Market At Interpack 5/22/2026
  8. LOTTE Biologics Expands Antibody Manufacturing Agreement With Ottimo Pharma 5/18/2026

    LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic partnership.

  9. AGC Biologics Joins Orphan Therapeutics Accelerator's Clinical Development Network As A Manufacturing Partner To Advance Cell And Gene Therapies For Ultra-Rare Diseases 5/14/2026

    Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has joined OTXL’s Clinical Development Network (Orphan ClinDevNet) as a manufacturing partner.

  10. Aldevron And Minaris Renew Lentiviral Plasmid Agreement 5/14/2026

    FARGO, N.D. & PHILADELPHIA–(BUSINESS WIRE)–Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider today announced a renewed licensing agreement that expands access to a proprietary, off-the-shelf lentiviral plasmid system for gene-modified cell therapy applications.